BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21900081)

  • 41. ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.
    Blackwood EA; Hofmann C; Santo Domingo M; Bilal AS; Sarakki A; Stauffer W; Arrieta A; Thuerauf DJ; Kolkhorst FW; Müller OJ; Jakobi T; Dieterich C; Katus HA; Doroudgar S; Glembotski CC
    Circ Res; 2019 Jan; 124(1):79-93. PubMed ID: 30582446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
    Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
    Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
    Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
    FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
    Menghini R; Menini S; Amoruso R; Fiorentino L; Casagrande V; Marzano V; Tornei F; Bertucci P; Iacobini C; Serino M; Porzio O; Hribal ML; Folli F; Khokha R; Urbani A; Lauro R; Pugliese G; Federici M
    Gastroenterology; 2009 Feb; 136(2):663-72.e4. PubMed ID: 19027012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
    Sadoshima J; Montagne O; Wang Q; Yang G; Warden J; Liu J; Takagi G; Karoor V; Hong C; Johnson GL; Vatner DE; Vatner SF
    J Clin Invest; 2002 Jul; 110(2):271-9. PubMed ID: 12122119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner.
    Awad AE; Kandalam V; Chakrabarti S; Wang X; Penninger JM; Davidge ST; Oudit GY; Kassiri Z
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C679-92. PubMed ID: 20007453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asiatic Acid Attenuates the Progression of Left Ventricular Hypertrophy and Heart Failure Induced by Pressure Overload by Inhibiting Myocardial Remodeling in Mice.
    Si L; Xu J; Yi C; Xu X; Ma C; Yang J; Wang F; Zhang Y; Wang X
    J Cardiovasc Pharmacol; 2015 Dec; 66(6):558-68. PubMed ID: 26647013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
    Kaneko H; Anzai T; Horiuchi K; Kohno T; Nagai T; Anzai A; Takahashi T; Sasaki A; Shimoda M; Maekawa Y; Shimizu H; Yoshikawa T; Okada Y; Yozu R; Fukuda K
    Atherosclerosis; 2011 Oct; 218(2):470-8. PubMed ID: 21722904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired Protein Quality Control During Left Ventricular Remodeling in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor.
    Hartupee J; Szalai GD; Wang W; Ma X; Diwan A; Mann DL
    Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin-E2 receptor-4 stimulant rescues cardiac malfunction during myocarditis and protects the heart from adverse ventricular remodeling after myocarditis.
    Takakuma A; Nishii M; Valaperti A; Hiraga H; Saji R; Sakai K; Matsumura R; Miyata Y; Oba N; Nunose F; Ogawa F; Tamura K; Takeuchi I
    Sci Rep; 2021 Oct; 11(1):20961. PubMed ID: 34702968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
    Walker EJ; Rosenberg GA
    Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TIMP3 checks inflammation.
    Black RA
    Nat Genet; 2004 Sep; 36(9):934-5. PubMed ID: 15340428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
    Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
    Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of adverse remodelling by osteopontin in a genetic heart failure model.
    Psarras S; Mavroidis M; Sanoudou D; Davos CH; Xanthou G; Varela AE; Panoutsakopoulou V; Capetanaki Y
    Eur Heart J; 2012 Aug; 33(15):1954-63. PubMed ID: 21525025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism.
    Accornero F; van Berlo JH; Benard MJ; Lorenz JN; Carmeliet P; Molkentin JD
    Circ Res; 2011 Jul; 109(3):272-80. PubMed ID: 21636802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis.
    Mahmoodi M; Sahebjam S; Smookler D; Khokha R; Mort JS
    Am J Pathol; 2005 Jun; 166(6):1733-40. PubMed ID: 15920158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
    Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
    J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.